Literature DB >> 18580053

Clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis patients.

Ea Wha Kang1, Ju Young Nam, Tae-Hyun Yoo, Suk Kyun Shin, Shin-Wook Kang, Dae-Suk Han, Seung Hyeok Han.   

Abstract

BACKGROUND: Despite the high prevalence of subclinical hypothyroidism in patients with chronic kidney disease, little is known about the clinical features and implications of this disorder in end-stage renal disease patients. This study aimed to investigate the clinical implications of subclinical hypothyroidism in continuous ambulatory peritoneal dialysis (CAPD) patients.
METHODS: This is a cross-sectional study with 51 stable patients who were maintained on CAPD for more than 3 months. A thyroid function test with blood sampling and echocardiography were conducted. Subclinical hypothyroidism was defined as a thyrotropin (TSH) level over 5 mIU/l and normal free T(4).
RESULTS: Of the 51 patients, subclinical hypothyroidism was detected in 14 (27.5%). Among those with subclinical hypothyroidism, only 4 (28.6%) patients had autoimmune thyroiditis. Patients with subclinical hypothyroidism had lower left ventricular ejection fractions (LVEF; 61.5 vs. 70.0%, p = 0.002) and lower fractional shortening at endocardial levels (endoFS; 33.9 vs. 40.0%, p = 0.009) compared to those with normal TSH levels. In addition, logTSH was inversely associated with LVEF (r = -0.361, p = 0.009) and endoFS (r = -0.320, p = 0.022). In a multivariate linear regression, adjusted for age, diabetes, previous coronary artery disease and logCRP (C-reactive protein), logTSH was an independent correlate with LVEF (beta = -0.388, p < 0.001).
CONCLUSION: This study suggests that subclinical hypothyroidism is common and might be implicated in cardiac dysfunction in CAPD patients. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580053     DOI: 10.1159/000141933

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  17 in total

1.  Thyrotropin and free thyroxine concentrations do not affect cardiovascular disease and mortality in euthyroid peritoneal dialysis patients.

Authors:  Sara Romero Pérez; Juan Jose Díez; María Auxiliadora Bajo; Pedro Iglesias; Cristina Grande; Gloria del Peso; Rosario Madero; Marta Ossorio; Rafael Selgas
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

2.  The association between thyroid hormones and arterial stiffness in peritoneal dialysis patients.

Authors:  Erhan Tatar; Meltem Sezis Demirci; Fatih Kircelli; Ozkan Gungor; Mustafa Yaprak; Gulay Asci; Ali Basci; Mehmet Ozkahya; Ercan Ok
Journal:  Int Urol Nephrol       Date:  2011-07-22       Impact factor: 2.370

Review 3.  An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.

Authors:  Gaosi Xu; Wenjun Yan; Jingzhen Li
Journal:  Clin Exp Nephrol       Date:  2014-04-22       Impact factor: 2.801

4.  Importance of specific reference values for evaluation of the deteriorating thyroid function in patients with end-stage renal disease on hemodialysis.

Authors:  Toru Sanai; Ken Okamura; Tomoya Kishi; Motoaki Miyazono; Yuji Ikeda; Takanari Kitazono
Journal:  J Endocrinol Invest       Date:  2014-07-05       Impact factor: 4.256

Review 5.  Thyroid disease in end-stage renal disease.

Authors:  Connie M Rhee
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-11       Impact factor: 2.894

6.  Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population.

Authors:  Yee Yung Ng; Shiao Chi Wu; Hong Da Lin; Fen Hsiang Hu; Chun Cheng Hou; Yea Yun Chou; Shih Min Chiu; Ya Hui Sun; Sandy Shan-Ying Cho; Wu Chang Yang
Journal:  Perit Dial Int       Date:  2011-04-30       Impact factor: 1.756

Review 7.  Thyroid dysfunction and kidney disease: An update.

Authors:  Pedro Iglesias; María Auxiliadora Bajo; Rafael Selgas; Juan José Díez
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

8.  Thyroid Functional Disease and Mortality in a National Peritoneal Dialysis Cohort.

Authors:  Connie M Rhee; Vanessa A Ravel; Elani Streja; Rajnish Mehrotra; Steven Kim; Jiaxi Wang; Danh V Nguyen; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  J Clin Endocrinol Metab       Date:  2016-08-15       Impact factor: 5.958

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

Review 10.  The interaction between thyroid and kidney disease: an overview of the evidence.

Authors:  Connie M Rhee
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-10       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.